Is Fresenius Medical Care AG & Co. KGaA a good investment? Fresenius Medical Care AG & Co. KGaA (FME.DE) is currently trading at 41.65 EUR. Market analysts have a consensus price target of 43.78 EUR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 13.59. This relatively low multiple may signal that Fresenius Medical Care AG & Co. KGaA is undervalued compared to historical market norms.
Earnings Schedule: Fresenius Medical Care AG & Co. KGaA is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is 4.39.
For income investors, Fresenius Medical Care AG & Co. KGaA pays a dividend yield of 3.28%. With a payout ratio of 45%, the dividend appears sustainable.
Yes, it pays an annual dividend of 1.49 EUR (3.28% yield).
Fresenius Medical Care AG & Co. KGaA is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of 3.27.
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company operates through Care Delivery and Care Enablement segments. It also develops, manufactures, and distributes various health care products, including hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular specialty, ambulatory surgery center, physician nephrology practice management, pharmacy and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. The company was incorporated in 1996 and is headquartered in Bad Homburg, Germany.
| Year | Total Dividends |
|---|---|
| ▸2027 |
1.44 EUR
|
| May 17, 2027 (estimated) | 1.4401 |
| ▸2026 |
1.49 EUR
|
| May 27, 2026 | 1.4900 |
| ▸2025 |
1.44 EUR
|
| May 27, 2025 | 1.4400 |
| ▸2024 |
1.19 EUR
|
| May 22, 2024 | 1.1900 |
| ▸2023 |
1.12 EUR
|
| May 22, 2023 | 1.1200 |
| ▸2022 |
1.35 EUR
|
| May 17, 2022 | 1.3500 |
| ▸2021 |
1.34 EUR
|
| May 26, 2021 | 1.3400 |
| ▸2020 |
1.20 EUR
|
| Sept. 1, 2020 | 1.2000 |
| ▸2019 |
1.17 EUR
|
| May 21, 2019 | 1.1700 |
| ▸2018 |
1.06 EUR
|
| May 23, 2018 | 1.0600 |
| ▸2017 |
0.96 EUR
|
| May 16, 2017 | 0.9600 |
| ▸2016 |
0.80 EUR
|
| May 13, 2016 | 0.8000 |
| ▸2015 |
0.78 EUR
|
| May 20, 2015 | 0.7800 |
| ▸2014 |
0.77 EUR
|
| May 16, 2014 | 0.7700 |
| ▸2013 |
0.75 EUR
|
| May 17, 2013 | 0.7500 |
| ▸2012 |
0.69 EUR
|
| May 11, 2012 | 0.6900 |
| ▸2011 |
0.65 EUR
|
| May 13, 2011 | 0.6500 |
| ▸2010 |
0.61 EUR
|
| May 12, 2010 | 0.6100 |
| ▸2009 |
0.58 EUR
|
| May 8, 2009 | 0.5800 |
| ▸2008 |
0.54 EUR
|
| May 21, 2008 | 0.5400 |
| ▸2007 |
1.41 EUR
|
| May 16, 2007 | 1.4100 |
| ▸2006 |
1.35 EUR
|
| May 10, 2006 | 1.2300 |
| Feb. 13, 2006 | 0.1200 |
| ▸2005 |
1.12 EUR
|
| May 25, 2005 | 1.1200 |
| ▸2004 |
1.02 EUR
|
| May 28, 2004 | 1.0200 |
| ▸2003 |
0.94 EUR
|
| May 23, 2003 | 0.9400 |
| ▸2002 |
0.85 EUR
|
| May 23, 2002 | 0.8500 |
| ▸2001 |
0.78 EUR
|
| May 25, 2001 | 0.7800 |
| ▸2000 |
0.69 EUR
|
| May 31, 2000 | 0.6900 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | May 27, 2026 | Paid | 1.49 EUR |
| Split Date | Split Ratio to 1 |
|---|---|
| June 18, 2007 | 3.000000 |
Community Discussion